Ninety-three experimental rats were exposed to cigarette smoke for a period of 12 weeks, and they developed pathological lung alterations similar to those of COPD patients. Except of its antioxidative properties Myrtol® standardized (GeloMyrtol® / GeloMyrtol® forte) can have an anti-inflammatory effect, by the inhibition of cytokine production. Cellular ROS and tumor necrosis factor (TNF)-alpha, interleukin (IL)-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion were measured after 4 h and 20 h, respectively.

auch vor dem SchlafengehenKinder von 6-10 Jahren (mit 20-29 kg Körpergewicht )1 KapselKinder von 6-10 Jahren (mit 20-29 kg Körpergewicht )vor der Mahlzeit (ca. shown that the oral application of Myrtol® standardized significantly reduced the formation of leukotriene C4/D4/E4 based on the Opas et al. The effect of GeloMyrtol ® forte is based on the special combination of high quality essential oils. In a special process, a special distillate is obtained from four different plants: eucalyptus, sweet orange, myrtle and lemon.It was shown that Myrtol® standardized and eucalyptus oil can ameliorate the inflammatory processes by interfering to the leukocyte activation. The herbal expectorant GeloMyrtol ® forte is suitable and well tolerated for children from 6 years of age.

The potential advantages toward antibiotic therapy, such as the development of resistance and side effects, give clinicians a therapeutic alternative, especially in cases when diagnosis of bacterial infection is getting dubious. GeloMyrtol ® and GeloMyrtol ® forte, also known as Myrtol ® standardized, is an herbal medical product (phytomedicine) obtained by a multistep distillation procedure from essential oils. After 2 weeks of treatment, a significant improvement of clinical symptoms, blood gas analysis parameters (PaO 2/FiO 2 and PaCO 2), and pulmonary function parameters (forced expiratory volume [FEV] 1 and FEV1%) was observed in patients treated with Myrtol® standardized in comparison to the control group.The first study to date the secretolytic and secretomotoric effects of GeloMyrtol® forte was performed in vivo in healthy volunteers and published on 1995 from Behrbohm et al.